Registration

THE INGRAM GROUP LLC for ELI LILLY AND COMPANY

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Biopharmaceutical-related IP protection issues, including those associated with the MODDERN Cures Act (H.R. 3116, 113th Cong.) and Dormant Therapies Act (S. 3004, 113th Cong.).

LobbyistCovered position, as disclosed
BEECHER FRASIER New Chief of Staff, Congressman Lincoln Davis
TOM INGRAM New CoS,Sen.LamarAlexander;StaffDir,SenRepubConf
DANIEL M MCCARTHY New Legislative Asst, WH Office of Legislative Affairs
JOHN MILNE New —
BERNARD TOON New SrStaff,SenForeignRel;COSDorganBingamanBidenBradleyRoemer
JEFFREY STUART WIENER New Legislative Assistant, Senator Mary Landrieu

Bills named: H.R. 3116 (114th), S. 3004 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.